| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |